我们的网站为什么显示成这样?

可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:

|本期目录/Table of Contents|

尿微量白蛋白与冠心病支架植入术后1年再狭窄的相关性

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2013年第2期
页码:
197-199
栏目:
临床研究
出版日期:
2013-04-25

文章信息/Info

Title:
Correlation of microalbuminuria and coronary stenting restenosis 1 year after percutaneous coronary intervention
作者:
艾 民颜昌福夏福纯周双陆贺 剑顾定平付国齐
(攀钢总医院心内科,四川 攀枝花 617023)
Author(s):
AI Min YAN Chang-fu XIA Fu-chun ZHOU Shuang-lu HE Jian GU Ding-ping FU Guo-qi
(Department of Cardiology, Pangang General Hospital of Panzhihua, Panzhihua 617023, Sichuan, China)
关键词:
冠状动脉疾病支架内再狭窄微量白蛋白尿
Keywords:
coronary heart disease in-stent restenosis microalbuminuria
分类号:
R541.4
DOI:
-
文献标识码:
A
摘要:
目的:分析尿微量白蛋白(MAU)与冠心病患者行支架植入术后1年支架内再狭窄的相关性。方法: 收集2009年3月~2011年6月我科139例冠心病经皮冠状动脉介入治疗患者,支架植入术前检测患者MAU,术后1年根据患者冠状动脉造影结果分为再狭窄组和未狭窄组。结果: 再狭窄组患者MAU水平[(59±16) mg/L]显著高于未狭窄组患者[(39±15) mg/L] (P<0.05);再狭窄组中单支病变[(40±3) mg/L]、两支病变[(55±5) mg/L]和三支病变[(82±11) mg/L]患者MAU水平比较差异有统计学意义(P<0.05)。结论: 冠心病患者支架植入术后1年支架内再狭窄与患者支架术前的MAU水平相关,MAU是支架术后再狭窄的很好预测指标。
Abstract:
AIM:To explore the correlation of microalbuminuria (MAU) and stent restenosis 1 year after percutaneous coronary intervention (PCI). METHODS: Serum microalbuminuria was tested in patients prior to PCI. One year after PCI, patients were divided into restenosis group and no-restenosis group by coronary artery angiography and the results were compared. RESULTS: Serum microalbuminuria levels (59±16) mg/L in restenosis group were significantly higher than in the no-restenosis group (39±15) mg/L (t=4.316, P<0.05). Serum MAU levels were, respectively, (40±3) mg/L in single-vessel lesions, (55±5) mg/L in two-vessel lesions, and (82±11) mg/L in three-vessel lesions (F value = 61.426, P<0.05). The difference was statistically significant. CONCLUSIONS: Microalbuminuria is a good predictive index for coronary artery stent restenosis 1 year after PCI.

参考文献/References

[1]Hillege HL,Fidler V,Diercks GF,et al.Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population[J].Circulation,2002,106(14):1777-1782.
[2]Hanevold CD,Pollock JS,Harshfield GA,et al.Racial differences in microalbumin excretion in healthy adolescents[J].Hypertension,2008,51(2):334-338.
[3]GibbonsRJ,Chatte K,Daley J,et al.ACC/AHA/ACP-ASIM guidelines for the management of Patients with chronic stable angina: exeeutive summary and recommendations[J].Circulation,1999,99(21):2829-2848.
[4]Gibbons RJ,Abralms J, Chatterjee K,et al.ACC/AHA 2002 guidelines update for the management of patients with chronic stable angina-summary article: a report of the American college of Cardiology/Aineriea Heart Association Task Force on practice guideline (Committee on the Management of Patients With Chronic Stable Angina)[J].Circulation,2003,107(l):149-158.
[5]Yudkin JS,Forrest RD,Jackson CA.Microalbuminuria as predictor of vas-cular disease innon-diabetic subjects: Islington diabetessurvey[J].Lancet,1988,2(3):530-533.
[6]Borch-Johnsen K,Feldt-Rasmussen B,Strandgaard S,et al.Urinary albumin excretion.An independent predictor of ischemic heart disease[J].Arterioscle Thromb Vasc Biol,1999,19(8):1992-1997.
[7]Man JF,Gersten HC,Pogue J,et al.Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril:the HOPE randomized trial[J].Ann Intern Med,2001,134(8):629-636.
[8]Hillege HL,Fidler V,Diercks GF,et al.Urinary albumin Excretion predicts cardiovascular and noncardiovascular mortality in general population[J].Circulation,2002,106(8):1777-1782.
[9]Mojiminiyi OA,Abdella N,Moussa MA,et al.Association of Creaetive protein with coronary heart disease risk factors in patients with type 2 diabetes mellitus[J].Diabetes Res Clin Pract,2002,58(7):37-44.
[10]Erbagei AB,Tarakcioglu M,Coskun Y,et al.Mediators of inflammation in children with type 1 diabetes mellitus:eytokines in type 1 diabetic children[J].Clin Biochem,2001,34(8):645-650.
[11]Hoseini VN,Rasouli M.Mieroabluminuria correlates with the prevalence and severity of coronary artery disease in non-diabetic patients[J].Cardiol J,2009,16(2):142-145.
[12]Yuyun MF,Khaw KT,Luben R,et al.A prospective study of rnicroalbuminuria and ineident coronary heart disease and its prognostic significance in a British population: the EPIC-Norfolk study[J].Am J Epidemiol,2004,159(3):284-293.
[13]Arnlor J,Evans JC,Meigs JB,et al.Low-grade albuminuria and incidence of cardiovascular disease event in non-hypertensive and nondiabetic individuals:the Framingham Heart Study[J].Circulation,2005,112(7):969-975.

备注/Memo

备注/Memo:
收稿日期:2012-09-13.通讯作者:颜昌福,主任医师,主要从事冠心病及心律失常介入治疗研究Email:YANCHANGFU2012@163.com 作者简介:艾民,副主任医师,博士 Email:aimin2006120@163.com
更新日期/Last Update: 2013-04-28